OHAIDP develops, coordinates, and supports initiatives to promote HHS policies, programs, and resources in the United States in three main areas:
- Blood and Tissue Safety and Availability
- HIV Prevention, Care, and Treatment
- Viral Hepatitis Prevention, Care, and Treatment
The Office of HIV/AIDS and Infectious Disease Policy coordinates OASH activities related to blood and tissue safety and availability in the United States. Activities include support for the Advisory Committee on Blood and Tissue Safety and Availability, coordination of activities across HHS agencies, and research to assess the screening, collection, utilization, and availability of blood and tissue products.
Advisory Committee on Blood and Tissue Safety and Availability
The ACBTSA is a 31-member federal advisory committee that provides advice to the HHS Secretary and the Assistant Secretary for Health on a range of policy issues that includes: 1) identification of public health issues through surveillance of blood and tissue safety issues with national biovigilance data tools; 2) identification of public health issues that affect availability of blood, blood products, and tissues; 3) broad public health, ethical and legal issues related to the safety of blood, blood products, and tissues; 4) the impact of various economic factors on safety and availability of blood, blood products, and tissues; 5) risk communications related to blood transfusion and tissue transplantation; and 6) identifcation of infectious disease transmission issues for blood, organs, blood stem cells and tissues.
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
The BOTSEC is an advisory forum for senior leadership from HHS organizational components, as well as liaison representatives from the Department of Defense and Veterans’ Health Administration, that are involved in blood, organ, and tissue safety and availability. The HHS Assistant Secretary for Health serves as the Council Chair, and the OASH Senior Advisor for Blood and Tissue Policy serves as the BOTSEC Executive Director.
National HIV/AIDS Strategy
The National HIV/AIDS Strategy (NHAS) is the nation’s road map for responding to HIV in the United States. It identifies priorities and strategic action steps that are based on the best available data, scientific evidence, and the accumulated experience of states, cities, and communities. The Strategy was developed with subject matter experts from across the federal government and extensive community consultation and stakeholder input. The initial Strategy was released in July of 2010. In July 2015, the National HIV/AIDS Strategy for the United States: Updated to 2020 was released. This update reflects the major scientific advances and programmatic progress since 2010. It charts a course for collective action across the Federal government and all sectors of society to move us close to the Strategy’s vision.
The Director of OHAIDP co-chairs, with the Director of the White House Office of National HIV/AIDS Policy, the cross-departmental Federal Interagency Working Group that updated the Strategy and is coordinating and monitoring its implementation. Within HHS, OHAIDP leads efforts to coordinate operational and programmatic activities related to implementation of the strategy across operating divisions and staff offices. This includes convening cross-departmental meetings to coordinate program planning and implementation, reviewing draft HIV-related funding announcements prior to publication; and participating in efforts to monitor progress toward the Strategy’s goals. In addition, OHAIDP is tasked with leading or supporting a number of activities detailed in the NHAS Federal Action Plan.
Presidential Advisory Council on HIV/AIDS (PACHA)
The PACHA is a 25-member federal advisory committee that provides advice, information, and recommendations to the HHS Secretary regarding programs and policies intended to promote effective prevention of HIV disease, and to advance research on HIV disease and AIDS. The White House asks PACHA to provide, on an ongoing basis, recommendations on how to effectively implement the National HIV/AIDS Strategy, as well as monitor the strategy's implementation.
Established by Congress in 1999 in response to growing concern about the disproportionate impact of HIV/AIDS on racial and ethnic minorities in the U.S., the Minority AIDS Initiative (MAI) includes an annual allocation of resources to the HHS for the Secretary’s MAI Fund (SMAIF), which is administered by OHAIDP on behalf of OASH and OS. SMAIF distributes about $54 million each year to HHS agencies and staff offices to support a wide range of activities that are designed to reduce new HIV infections, improve HIV-related health outcomes, and reduce HIV-related health disparities in racial and ethnic minority communities.
The projects supported by SMAIF promote innovation, address critical emerging issues, and have established new collaborations across Federal agencies. These projects are significant in that they are designed to complement – and not duplicate – other HIV prevention and care activities and to create lasting changes in Federal programs that improve the quality, efficiency and impact of HIV programs that serve racial and ethnic minorities.
OHAIDP administers HIV.gov, a cross-government web site, blog, and social media presence that seeks to expand visibility of and access to federally supported HIV information and services for people most at-risk for or living with HIV, particularly racial and ethnic minority communities. HIV.gov also highlights how social media can be an effective tool in the response to HIV. Among its activities, HIV.gov holds monthly meetings of the Federal HIV/AIDS Web Council to coordinate activities and facilitate cross-promotion of key agency, department, and administration HIV messages, policies, and resources. HIV.gov also provides technical assistance to help HIV program staff be more comfortable and engaged with social media.
HIV Health Improvement Affinity Group
The HIV Health Improvement Affinity Group (HHIAG) offers federal support for state-level efforts to improve rates of sustained virologic suppression among Medicaid and Children’s Health Insurance Program (CHIP) enrollees who are living with HIV. Those efforts are guided by teams made up of state public health and Medicaid/CHIP agencies, who will collaborate to develop and implement performance improvement projects that address gaps along the HIV care continuum for Medicaid/CHIP enrollees.
The HHIAG is a joint initiative between the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), and the Health Resources and Services Administration (HRSA), in collaboration with the HHS Office of HIV/AIDS and Infectious Disease Policy, and in partnership with the National Academy for State Health Policy.
National Viral Hepatitis Action Plan
The National Viral Hepatitis Action Plan 2017-2020 is a new phase in the nation’s fight against viral hepatitis in the United States and responds to recent trends in viral hepatitis infections and deaths, as well as new and improved strategies for prevention, care, and treatment. The National Viral Hepatitis Action Plan 2017 – 2020 presents a vision, goals, strategies, and indicators that will be used to track progress between now and 2020. The plan was developed collaboratively by 21 federal partners from the U.S. Departments of Health and Human Services, Housing and Urban Development, Justice, and Veterans Affairs with input from nonfederal stakeholders.
The Viral Hepatitis Action Plan was first released by HHS in May 2011 to better focus and coordinate our nation’s response to viral hepatitis. The plan was updated in April 2014 detailing additional strategic actions to be undertaken beginning in 2014 and continuing through 2016.
Viral Hepatitis Implementation Group
In support of the efforts across HHS and its partners to implement the actions included in the National Viral Hepatitis Action Plan, the Office of HIV/AIDS and Infectious Disease Policy convenes a Viral Hepatitis Implementation Group (VHIG) charged with coordinating, supporting, and monitoring activities related to the Action Plan. The VHIG is chaired by the Director of OHAIDP, and members include representatives from across HHS and other federal agencies and departments including the Departments of Housing and Urban Development, Justice, and Veterans Affairs. VHIG members meet regularly throughout the implementation of the Action Plan and have served as representatives within their respective agencies and offices on matters related to viral hepatitis.
Viral Hepatitis Website
The HHS Viral Hepatitis website, administered by OHAIDP, was developed to improve access to information about viral hepatitis and the federal response, highlighting the cross-governmental National Viral Hepatitis Action Plan 2017 - 2020, highlighting and encouraging efforts that support the plan’s goals, and sharing in one place links to information on relevant resources, programs, and policies located websites across the federal government